Recombinant Human TRAIL/TNFSF10/CD253 (Val114-Gly281, C-6His)

Recombinant Human TRAIL/TNFSF10/CD253 (Val114-Gly281, C-6His)

Catalog Number:
P001410867ABE
Mfr. No.:
Abe32-8284
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • MW : 20.6kD. Recombinant Human TNF-related Apoptosis-inducing Ligand is produced by our E.coli expression system and the target gene encoding Val114-Gly281 is expressed with a 6His tag at the C-terminus. Human TNFSF10 is a type II transmembrane protein with an intracellular N-terminus and a ‘TNF homology domain’ (THD) at the extracellular C terminus. TNFSF10 can interact with several distinct receptors. Two of these receptors that belongs to TNFR superfamily, DR4 (TRAIL-R1) and DR5 (TRAIL-R2/TRICK2), are plasma membrane proteins containing intracellular death domains essential for activating apoptosis. TNFSF10 is promising for cancer therapy because it is cytotoxic and activates apoptosis in the majority of malignant cells, but not in normal cells.

          Please contact us at for specific academic pricing.

      • Properties
        • Source
          E. coli
          Type
          Recombinant Proteins
          Formulation
          Lyophilized from a 0.2 µm filtered solution of 20mM PB, 150mM NaCl, pH7.4.
          Storage
          Lyophilized protein should be stored at -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at -20°C for 3 months.
          Endotoxin
          Less than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.

          More Information

          UniProt
          Gene ID
          8743

          * For Research Use Only. Not for use in diagnostic/therapeutics procedures.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.